Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
"IMO, ADXS doesn't want to have the qtry call until they can provide a positive update that they recently closed a capital raise to put more $$$ on the balance sheet funding the company into Q2 2019, etc. "
I think the recent dilution would not be part of the earnings report, so they are two separate events....
Next Earnings Report will show the dilution
"one day your loaned shares will default"
Can you please explain more? My understanding was that no matter what the price, the shorter has to return the share back after loaning?
Honestly... I don't know what is really going on here... nobody does
We can only speculate at this point... and I am only pointing out that a buyout or short covering are both speculations right now, not a reality.
"I’m just glad I got to finally experience a massive short covering. But when it happen to Adxs, the sp tanks. Ya gotta love it.....glta"
This is still a fantasy dreamt up on this message board just like the buyout fantasy....
Let's see what the next short interest report will show us
"1M shares traded in the last 45 minutes yet only up 6 cents. Where did they find the shares. Very strange, but we should find out soon IMO. Maybe in the AM?"
This makes no sense... how can a stock's daily 8 hour volume occur in 45 mins and the stock price not move?
IMO, Today's crazy closing volume is hinting on a news release or earnings release soon....
A pure speculation, but let's see what happens this week
Did anyone notice how like 70% or more of today's volume occurred in the last half-hour from 3:30PM to 4:00PM?
ADXS next quarterly report expectation:
1. Lots of money spent
2. Lots of future this and that
3. No real progress: Every milestone of Q4 2017 missed. I MEAN COME'ON, NOT ONE OR TWO, BUT EVERY SINGLE MILESTONE MISSED
OtherS who don't even own LM platform were able to show real progress on LM platform - PETX.
LOL... Some of the folks on this board are invested in ONCS for that very reason... an expectation that DOC is gonna spike up ONCS before the multiyear drain down to $0....
Speaking of DOC....
It's funny how DOC's ONCS which has MERK's keytruda plus electric currents as a medical Pipeline has a higher stock price than ADXS, which is in a phase 3 immuno-oncology trail with FDA's SPA, Fast Track and Orphan Drug designations (whose Phase 2 by the way made new Guinness World Record of 12 Month survival)
I like the ADXS daily volume above 1 million every day now
Agreed, very difficult to predict what route ADXS is really on, especially with the latest cash raise....
Two and half weeks left when ADXS Management shows their faces to investors with pitch forks!!!
ADXS Management has mentioned New CEO, and never said anything about sale...
So my vote is new CEO and/or partnerships....
A sale is nothing but a fantasy created on this message board.....
IMHO, ADXS doesn't need buyout... ADXS needs a momentum just like when it went from $2 to $30, and just like when it went from $8 to $16.....
Another good post worth repeating:
"Another reason for HOT+NEO combo is a single biopsy may not contain all the tumor assoc. mutations as lesions are heterogeneous."
What was the date of stock options for Sara and Petit being encouraged not to leave ADXS following DOC's departure?
Excellent post blue.
"Clarity on NEO and HOT: When a patient is diagnosed in a part of the world where there are`nt high tech hospitals,HOT will be used to start the treatment,and then NEO can be available within around 6 weeks of starting the HOT treatments."
That can be said for all parts of the world, high tech or not.... HOT can be started right away to get the patient going...
Calendar
Agreed and good post
NEO IND was supposed to be Q1 2018 and first patient dosed 1H 2018...
However, I don't see the Q1 2018 target of NEO IND in ADXS Slides anymore....
As I said several months ago... If I were TL and I knew that I am going to replaced by a permanent CEO....
My only motivation would be to milk the ADXS cow as much as I can... why do any hard work
The dilution just closed, so it will be some time if Denner decides to buy back in after his 100% exist before dilution
Try this link, it shows Sarissa Capital closing out on 2/23/18
https://fintel.io/so/us/adxs
You didn't read it clearly Keithz ....
The sign said "Gone finishing" cuz he's about finished with shareholder value only $1.80 or so remaining
"When investors like Alex Denner (The 25 most influential people in biopharma today) dumping shares for loss, it has to be something wrong with the science. "
Or maybe he found out or speculated that dilution is coming to ADXS...
Also, Denner had only chump change in ADXS, nothing significant...
I am still in question on how Denner timed his 100% exit right before dilution announcement.... This is messed up as these big guys in on the stuff together IMO
Thanks for the clarification hovacre
"ADXS Phase 4 trail has FDA's SPA... which means that the trail parameters have been agreed upon upfront...
FDA will not require additional trails"
Correction: meant to say Phase 3 trail
ADXS Phase 4 trail has FDA's SPA... which means that the trail parameters have been agreed upon upfront...
FDA will not require additional trails
ADXS NEO IND re-filing at FDA is scheduled Q1 2018
ADXS NEO dosing to begin by 1H 2018
Checkout this interesting link: Apparently ADXS has been using a company called Destum to make some of its big deals...
http://www.destumpartners.com/success/advisory-success/
So ADXS Market Cap after dilution is $75 Million?
And ADXS Cash on Hand is about the same?
Any biotech investor or biotech investing tute should be closing its eyes and buying ADXS at this level....
ADXS current price level cannot be logically explained....
You're kidding right?
"Dude I appreciate your tenacity in this forum and I would go to war with you any day. You can be my General...!
Lets Go ADXS....time to take back $2....!"
Translation: CLASS ACTION LAWSUIT against ADXS if BOD doesn't deliver soon
I will be in that line also
Some insight was provided from folks here on combining ADXS ADVANCE
1. Reduce cash burn, I took it as no more ADXS DUAL (which is good riddance to free loaders)
2. ADXS folks may have gotten the confidence that ADXS LM on its own is remarkable for HPV so far that there may not be a need for combos...
Hovacre, that email is dated July 2017.... not valid anymore IMO
"Not yet, although the stock offering should close today, which will be announced today or tomorrow. This is often follow by an appreciation in stock price."
Thanks for that comment, I was deciding wait until after closing to buy more, but going to buy today.
"End stage cervical trial with BMY is suppose to start this year "
I think that got canned... ADXS is combining all cervical trails as ADXS ADVANCE trail.
Which is good thing because NO MORE FREEBIES TO BIG PHARMA...
ADXS has full time director or whatever her title is... her only job is to make deals... if she can't do that, time for a better deal maker
"I expect new CEO to be announced within next 2 weeks."
We were expecting a buyout / deal since July 2017 cuz that's what Tony was supposedly good at...
Be prepared to see that ADXS Management is worst than dummies.... like literally, a car crash dummy with no brain could run ADXS better than the morons in charge right now
Theory number 3: ADXS Management has no clue and diluted cuz they running out of cash.... that simple
Yes enhanced is more pay to ASCO... but what is the return to ADXS or any other company?
In other words, could it be ADXS is planning to be an ASCO star with ADXS-PSA (possibly?)